Ezetimibe + other lipid-lowering medication(s) ( DrugBank: Ezetimibe )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
260	シトステロール血症	2

260. シトステロール血症

---

臨床試験数 : 13 /  薬物数 : 13 - (DrugBank : 4) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00705211 (ClinicalTrials.gov)	June 2007	23/6/2008	A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)	Designated Drug Use Investigation (Long-Term Administration) of Zetia 10-mg Tablets - A 52-Week Long-Term Designated Drug Use Investigation of Zetia Monotherapy and Combination Therapy	Hypercholesterolemia;Familial Hypercholesterolemia;Homozygous Sitosterolemia	Drug: Ezetimibe;Drug: Ezetimibe + other lipid-lowering medication(s)	Organon and Co	Bayer	Completed	N/A	N/A	All	1794		NULL
2	NCT00704444 (ClinicalTrials.gov)	June 2007	23/6/2008	A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)	Designated Drug Use Investigation (12 Weeks) of Zetia 10mg Tablets - A 12-Week Designated Drug Use Investigation of Zetia Monotherapy and Combination Therapy	Hypercholesterolemia;Familial Hypercholesterolemia;Homozygous Sitosterolemia	Drug: Ezetimibe;Drug: Ezetimibe + other lipid-lowering medication(s)	Organon and Co	Bayer	Completed	N/A	N/A	All	11332		NULL